Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis

Amyloid

Volumn 18, Issue 4, 2011, Pages 216-221

  Palladini, Giovanni ^a   Barassi, Alessandra ^b   Perlini, Stefano ^a   Milani, Paolo ^a   Foli, Andrea ^a   Russo, Paola ^a   Albertini, Riccardo ^c   Obici, Laura ^a   Lavatelli, Francesca ^a   Sarais, Gabriele ^a,c   Casarini, Simona ^a   Moratti, Remigio ^c   Melzi D'Eril, Gian Vico ^b   Merlini, Giampaolo ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

B type natriuretic peptide; Heart; Prognosis; Staging; Survival; Troponin

Indexed keywords

MIDREGIONAL PROADRENOMEDULLIN; PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ADULT; AGED; AL AMYLOIDOSIS; AMYLOIDOSIS; ARTICLE; CONCENTRATION (PARAMETERS); DIASTOLE; DISEASE MARKER; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAGING; SURVIVAL; SYSTOLE;

ADRENOMEDULLIN; AGED; AMYLOID; AMYLOIDOSIS; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; TROPONIN I;

EID: 81255165725     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.627069     Document Type: Article

References (31)

1. Merlini G, Stone MJ. Dangerous small B-cell clones. Blood 2006;108:2520-2530.
2. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005;1753: 11-22. (Pubitemid 41597427)
3. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, et al. Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212.
4. Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440-2445. (Pubitemid 36605226)
5. Dispenzieri A, Kyle RA, Gertz MA, Therneau TM, Miller WL, Chandrasekaran K, McConnell JP, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003;361:1787-1789. (Pubitemid 36638428)
6. Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, Obici L, et al. Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood 2006;107:3854-3858. (Pubitemid 43726787)
7. Palladini G, Barassi A, Klersy C, Pacciolla R, Milani P, Sarais G, Perlini S, et al. The combination of high-sensitivity cardiac troponin T (hscTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood 2010;116:3426-3430.
8. Kristen AV, Giannitsis E, Lehrke S, Hegenbart U, Konstandin M, Lindenmaier D, Merkle C, et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood 2010;116:2455-2461.
9. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-560. (Pubitemid 23227359)
10. Yanagawa B, Nagaya N. Adrenomedullin: Molecular mechanisms and its role in cardiac disease. Amino Acids 2007;32:157-164. (Pubitemid 44866583)
11. Temmesfeld-Wollbruck B, Hocke AC, Suttorp N, Hippenstiel S. Adrenomedullin and endothelial barrier function. Thromb Haemost 2007;98:944-951. (Pubitemid 350107695)
12. Kato J, Kobayashi K, Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996;81:180-183. (Pubitemid 26035022)
13. Miyao Y, Nishikimi T, Goto Y, Miyazaki S, Daikoku S, Morii I, Matsumoto T, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 1998;79:39-44. (Pubitemid 28179061)
14. Pousset F, Masson F, Chavirovskaia O, Isnard R, Carayon A, Golmard JL, Lechat P, et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 2000;21:1009-1014. (Pubitemid 30312090)
15. Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004;25:1369-1372. (Pubitemid 39180069)
16. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-167. (Pubitemid 32275593)
17. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, midregional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 2007;13:42-49. (Pubitemid 46343794)
18. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007;49:1525-1532. (Pubitemid 46517963)
19. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010;55: 2062-2076.
20. Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 2002;9:108-114. (Pubitemid 34787804)
21. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, et al. Serum cardiac troponins and N-terminal probrain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-3757. (Pubitemid 41095215)
22. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319-328. (Pubitemid 41098849)
23. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005;51:1823-1829. (Pubitemid 41368172)
24. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254. (Pubitemid 46768608)
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083. (Pubitemid 9091990)
26. Perlini S, Muiesan ML, Cuspidi C, Sampieri L, Trimarco B, Aurigemma GP, Agabiti-Rosei E, Mancia G. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation 2001;103:678-683. (Pubitemid 32144196)
27. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-1533. (Pubitemid 27486472)
28. Genesca J, Gonzalez A, Catalan R, Segura R, Martinez M, Esteban R, Groszmann RJ, Guardia J. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: Relationship to nitric oxide. Dig Dis Sci 1999;44:372-376. (Pubitemid 29093563)
29. Fabrega E, Crespo J, Casafont F, de La Pena J, Garcia-Unzueta MT, Amado JA, Pons-Romero F. Adrenomedullin in liver transplantation and its relationship with vascular complications. Liver Transpl Surg 1999;5:485-490. (Pubitemid 29517863)
30. Iinuma N, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Arai T, Yoshizawa T, Koyama T, et al. Adrenomedullin in sinusoidal endothelial cells play protective roles against cold injury of liver. Peptides 2010;31:865-871.
31. Russo P, Palladini G, Foli A, Zenone Bragotti L, Milani P, Nuvolone M, Obici L, et al. Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: Distinctive clinical features and role of light chain type in 225 patients. Amyloid 2011;18 Suppl 1:87-88.